Tradestie Institutional Equity Comparison Engine

GRAL vs BLLN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GRAL Overall Edge

GRAL Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GRAIL, Inc. Common Stock (GRAL) driven by superior Valuation, Momentum & Technical while BLLN counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus BLLN at 61.3x Forward P/E and 10.2% operating margin (+47.2% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against BLLN sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs BLLN 61.3x Fwd P/E
Growth & Margin Winner BLLN
Op Margin -332.0% vs 10.2% ยท YoY +3.7% vs +47.2%
Momentum & Technical Winner GRAL
1Y +24.6% vs +7.5% ยท 52W Pos 51% vs 39%
Options & Structure Winner BLLN
BREAKDOWN (53rd %ile IV) vs BREAKDOWN (26th %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
BLLN US Equity
BillionToOne, Inc.
Services-Medical Laboratories
$96.31
-8.41% 1D
Market Cap $5.0B
1M Return -1.84%
1Y Return +7.55%
Forward P/E 61.3x
Unified AI Score
45.8 / 100 HOLD
Tech 27.0 Fund 53.0 Flow 71.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% BLLN +7.55% Spread: +19.37 pp (GRAL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GRAL Revenue BLLN Revenue GRAL Op. Margin BLLN Op. Margin Margin Edge
FY2023 $90M $70M -1627.6% -96.9% BLLN
FY2024 $130M $150M -1743.0% -30.9% BLLN
FY2025 $150M $310M -382.0% 5.3% BLLN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (5) vs BLLN (5)
Institutional Metric GRAL BLLN Criterion Row Winner
Market Capitalization Scale $5.2B $5.0B Larger Scale GRAL
Trailing P/E Ratio Valuation 1.1x 114.3x Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x 61.3x Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +47.2% Higher Growth BLLN
Operating Margin (TTM) Profitability -332.0% 10.2% Higher Margin BLLN
Net Profit Margin Profitability -243.8% 10.5% Higher Margin BLLN
Return on Equity (ROE) Capital Efficiency -17.3% 13.2% Higher ROE BLLN
52-Week Range Position Momentum 51% ($42โ€“$166) 39% ($62โ€“$150) Stronger Trend GRAL
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 1.44ฮฒ ยท 42% Vol Lower Realized Risk BLLN
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 45.8 / 100 (HOLD) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs BLLN Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BLLN BREAKDOWN
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BLLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor BLLN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.